Aoki N, Maeda M, Kurata M, Hirose M, Ojima Y, Wada K, Shibuya Y. Sinus floor elevation with platelet-rich fibrin alone: A Clinical retrospective study of 1-7 years. J Clin Exp Dent. 2018;10(10):e984-91.





1. Sohn D, Moon JWMoon KNCho SCKang PS. New bone Formation in the maxillary sinus using only absorbable gelatin sponge. J Oral and Maxillofac Surg. 2010;68:1327-1333.


2. Borie E, Oliví DGOrsi IAGarlet KWeber BBeltrán V, et al. Platelet-rich fibrin application in dentistry: a literature review. Int J Clin and Exp Med. 2015;8:7922-7929.
PMid:26221349 PMCid:PMC4509294


3. Whitmann DH, Berry RL, Green DM. Platelet gel: an alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55:1294-1299.


4. Choukroun J, Adda F, Schoeffler C, Vervelle A. An opportunity in perio-implantology: The PRF (in French). Implantodontie. 2001;42:55-62.


5. Choukroun J, Diss ASimonpieri AGirard MOSchoeffler CDohan SL, et al. Platelet-rich fibrin (PRF): A second- generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:299-303.


6. Bolukbasi N, Ersanlı SKeklikoglu NBasegmez COzdemir T. Sinus augmentation with platelet-rich fibrin in combination with bovine bone graft versus bovine bone graft in combination with collagen membrane. J Oral Implantol. 2015;41:586-595.


7. Diss A, Dohan DMMouhyi JMahler P. Osteotome sinus floor elevation using Choukroun's platelet-rich fibrin as grafting material: a 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:572-579.


8. Toffler M, Toscano N, Holtzclaw D. Osteotome-mediated sinus floor elevation using only platelet-rich fibrin: An early report on 110 patients. Implant Dent. 2010;19:447-456.


9. Buser D, Mericske-Stern RBernard JPBehneke ABehneke NHirt HP, et al. Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective multi-center study with 2359 implants. Clin Oral Implants Res. 1997;8:161-172.


10. Si MS, Shou YWShi YTYang GLWang HMHe FM. Long-term outcomes of osteotome sinus floor elevation without bone grafts: a clinical retrospective study of 4-9 years. Clin Oral Implants Res. 2016;27:1392-1400.


11. Lemos CA, Mello CCdos Santos DMVerri FRGoiato MCPellizzer EP. Effects of platelet-rich plasma in association with bone grafts in maxillary sinus augmentation: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016;45:517-525.


12. He L, Lin YHu XZhang YWu H. A comparative study of platelet-rich fibrin(PRF) and platelet-rich plasma(PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:707-713.


13. Aoki N, Kanayama TMaeda MHorii KMiyamoto HWada K, et al. Sinus augmentation by platelet-rich fibrin alone: A report of two cases with histological examinations. Case Rep Dent. 2016; 2016:Epub.

PMid:27795860 PMCid:PMC5066024


14. Tanaka H, Toyoshima TAtsuta IAyukawa YSasaki MMatsushita Y, et al. Additional effects of platelet-rich fibrin on bone regeneration in sinus augmentation with deproteinized bovine bone mineral: Preliminary results. Implant Dent. 2015;24:669-674.



15. Rosen PS, Summers RMellado JRSalkin LMShanaman RHMarks MH, et al. The bone-added osteotome sinus floor elevation technique: Multicenter retrospective report of consecutively treated patients. Int J Oral Maxillofac Implants. 1999;14:853-858.


16. Kanayama T, Horii K, Senga Y, Shibuya Y. Crestal approach to sinus floor elevation for atrophic maxilla using platelet-rich fibrin as only grafting material: A 1-year prospective study. Implant Dent. 2016;25:32-38.


17. Kanayama T, Shibuya Y, Wada K, et al. Noticeable bone regeneration beyond the implant tip after a crestal approach sinus lift using only platelet rich fibrin: A report of two cases. OHDM. 2016;15:153-156.


18. Del Fabbro M, Corbella SWeinstein TCeresoli VTaschieri S. Implant survival rates after osteotome-mediated maxillary sinus augmentation: A systematic review. Clin Implant Dent Relat Res. 2012;14:e159-e168.


19. Toffler M. Osteotome-mediated sinus floor elevation: a clinical report. Int J Oral Maxillofac Implants. 2004;19:266-273.


20. Chrcanovic BR, Albrektsson T, Wennerberg A. Smoking and dental implants: a systematic review and meta-analysis. J Dent. 2015;43:487-498.


21. Chrcanovic BR, Kisch JAlbrektsson TWennerberg A. Bruxism and dental implant failures: a multilevel mixed effects parametric survival analysis approach. J Oral Rehabil. 2016;43:813-823.


22. Lundgren S, Andersson S, Sennerby L. Spontaneous bone formation in the maxillary sinus after removal of a cyst: coincidence or consequence?. Clin Implant Dent Relat Res. 2003;5:78-81.


23. Borges FL, Dias ROPiattelli AOnuma TGouveia Cardoso LASalomăo M, et al. Simultaneous sinus membrane elevation and dental implant placement without bone graft: a 6-month follow-up study. J Periodontol. 2011;82:403-412.


24. Nedir R, Nurdin NKhoury PPerneger THage MEBernard JP, et al. Osteotome sinus floor elevation with and without grafting material in the severely atrophic maxilla. A 1-year prospective randomized controlled study. Clin Oral Implants Res. 2013;24:1257-1264.


25. Nedir R, Nurdin NKhoury PBischof M. Short implants placed with or without grafting in atrophic sinuses: the 3-year results of a prospective randomized controlled study. Clin Implant Dent Relat Res. 2016;18:10-18.


26. Nedir R, Nurdin NAbi Najm SEl Hage MBischof M. Short implants placed with or without grafting in atrophic sinuses: the 5-year results of a prospective randomized controlled study. Clin Oral Implants Res. 2016;00:1-10.



27. Ali S, Bakry SA, Abd-Elhakam H. Platelet-rich fibrin in maxillary sinus augmentation: A systematic review. J Oral Implantol. 2015;41:746-753.


28. Proussaefs P, Lozada J, Kim JRohrer MD. Repair of the perforated sinus membrane with a resorbable collagen membrane: a human study. Int J Oral Maxillofac Implants. 2004;19:413-420.


29. Ardekian L, Oved-Peleg EMactei EEPeled M. The clinical significance of sinus membrane perforation during augmentation of the maxillary sinus. J Oral Maxillofac Surg. 2006;64:277-282.


30. Choi BH, Zhu SJJung JHLee SHHuh JY. The use of autologous fibrin glue for closing sinus membrane perforations during sinus lifts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:150-154.

1. Eversole LR, Laipis PJ. Oral squamous papillomas: detection of HPV DNA by in situ hybridization. Oral Surg Oral Med Oral Pathol. 1988;65:545-50.



2. Neville B, Damm D, Allen C, Chi A. Oral and Maxillofacial Pathology. 4th ed. St. Louis, MO: Elsevier; 2016.


3. Muller S, Gale N, Odell EW, Richardson M, Syrjanen S. Squamous cell papilloma. In: El-Naggar AK, Chan J, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumors. 4th ed. International Agency for Research on Cancer; 2017. p. 115-6.


4. Zeuss MS, Miller CS, White DK. In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol. 1991;71:714-20.


5. Dona MG, Pichi B, Rollo F, Gheit T, Laquintana V, Covello R, et al. Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas. Head Neck. 2017;39:254-9.


6. Khanal S, Cole ET, Joh J, Ghim SJ, Jenson AB, Rai SN, et al. Human papillomavirus detection in histologic samples of multifocal epithelial hyperplasia: a novel demographic presentation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:733-43.


7. Mills A, Balasubramaniam R, Longacre TA, Kong CS, Pinsky BA. Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues. Arch Pathol Lab Med. 2013;137:50-4.


8. Kocjan BJ, Hosnjak L, Poljak M. Detection of alpha human papillomaviruses in archival formalin-fixed, paraffin-embedded (FFPE) tissue specimens. J Clin Virol. 2016;76 Suppl 1:S88-97.


9. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol. 1998;153:1731-9.


10. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol. 1999 Sep;80 ( Pt 9)(Pt 9):2437-43.


11. Miller CS, Zeuss MS, White DK. In situ detection of HPV DNA in oral mucosal lesions. A comparison of two hybridization kits. J Oral Pathol Med. 1991;20:403-8.


12. Snietura M, Lamch R, Kopec A, Waniczek D, Likus W, Lange D, et al. Oral and oropharyngeal papillomas are not associated with high-risk human papillomavirus infection. Eur Arch Otorhinolaryngol. 2017;274:3477-83.


13. Ward KA, Napier SS, Winter PC, Maw RD, Dinsmore WW. Detection of human papilloma virus DNA sequences in oral squamous cell papillomas by the polymerase chain reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:63-6.


14. Park JS, Leake JF, Sharma BK, Toki T, Kessis TD, Ambros RA, et al. Variability in beta-globin and HPV DNA amplification by PCR from fixed tissues. Mod Pathol. 1991;4:667-70.


15. Odida M, de Sanjose S, Sandin S, Quiros B, Alemany L, Lloveras B, et al. Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer. Infect Agent Cancer. 2010;5:15,9378-5-15.


16. Steinau M, Patel SS, Unger ER. Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2011;13:377-81.
PMid:21704270 PMCid:PMC3123789


17. Cannavo I, Loubatier C, Chevallier A, Giordanengo V. Improvement of DNA extraction for human papillomavirus genotyping from formalin-fixed paraffin-embedded tissues. Biores Open Access. 2012;1:333-7.
PMid:23516673 PMCid:PMC3559202


18. Martin E, Dang J, Bzhalava D, Stern J, Edelstein ZR, Koutsky LA, et al. Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals. J Clin Virol. 2014;59:30-7.
PMid:24268765 PMCid:PMC3898882


19. de Villiers EM, Gunst K. Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesions. J Gen Virol. 2009;90:1999-2004.


20. Bottalico D, Chen Z, Dunne A, Ostoloza J, McKinney S, Sun C, et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis. 2011;204:787-92.
PMid:21844305 PMCid:PMC3156102


21. Ure AE, Forslund O. Characterization of human papillomavirus type 154 and tissue tropism of gammapapillomaviruses. PLoS One. 2014;9:e89342.
PMid:24551244 PMCid:PMC3923884


22. Fatahzadeh M, Schlecht NF, Chen Z, Bottalico D, McKinney S, Ostoloza J, et al. Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:505-14.
PMid:23375488 PMCid:PMC4011080


23. Lawton G, Thomas S, Schonrock J, Monsour F, Frazer I. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med. 1992;21:265-9.


24. Tristao W, Ribeiro RM, Oliveira CA, Betiol JC, Bettini Jde S. Epidemiological study of HPV in oral mucosa through PCR. Braz J Otorhinolaryngol. 2012;78:66-70.


25. Esquenazi D, Bussoloti Filho I, Carvalho Mda G, Barros FS. The frequency of human papillomavirus findings in normal oral mucosa of healthy people by PCR. Braz J Otorhinolaryngol. 2010;76:78-84.


26. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307:693-703.
PMid:22282321 PMCid:PMC5790188

1. Lindhe J, Meyle J. Peri-implant diseases: consensus report of the sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35:282-5.



2. Savli GE, Cosgarea R, Sculean A. Prevalence and mechanisms of peri-implant diseases. J Dent Res. 2017;96:31-7.


3. Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015;42:S158-71.


4. Heitz-Mayfield LJA. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol. 2008;35:292-304.


5. Kumar PS, Mason MR, Brooker MR, O'Brien K. Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J Clin Periodontol. 2012;39:425-33.
PMid:22417294 PMCid:PMC3323747


6. Koyanagi T, Sakamoto M, Takeuchi Y, Maruyama N, Ohkuma, M, Izumi Y. Comprehensive microbiological findings in peri-implantitis and periodontitis. J Clin Periodontol. 2013;40:218-26.


7. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1ß in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implnats Res. 2002;13:637-43.


8. Nomura T, Ishii A, Shimizu H, Taguchi N, Yoshie H, Kusakari H, et al. Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation. Clin Oral Implnats Res. 2000;11:430-40.


9. Duarte PM, Serrăo CR, Miranda TS, Zanatta LCS, Bastos MF, Faveri M, et al. Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review. J Periodont Res. 2016;51:689-98.


10. Dursun E, Tözüm TF. Peri-implant crevicular fluid analysis, enzymes and biomarkers: a systemic review. J Oral Maxillofac Res. 2016;7:e9.
PMid:27833734 PMCid:PMC5100649


11. Karring ES, Stavropoulos A, Ellegaard B, Karring T. Treatment of peri-implantitis by the Vector® system A pilot study. Clin Oral Implants Res. 2005;16:288-93.


12. Renvert S, Samuelsson E, Lindahl C, Persson GR. Mechanical non-surgical treatment of peri-implantitis: a double-blind randomized longitudinal clinical study. I: clinical results. J Clin Periodontol. 2009;36:604-9.


13. Muthukuru M, Zainvi A, Esplugues EO, Flemming TF. Non-surgical therapy for the management of peri-implantitis: a systemic review. Clin Oral Implnats Res. 2012;23:77-83.


14. Yamamoto A, Tanabe T. Treatment of peri-implantitis around TiUite-surface implants using Er: YAG laser microexplosions. Int J Periodontics Restorative Dent. 2013;33:21-9.


15. Yan M, Liu M, Wang M, Yin F, Xia H. The effects of Er: YAG on the treatment of peri-implantitis: a meta-analysis of randomized controlled trials. Lasers Med Sci. 2015;30:1843-53.


16. Shimada Y, Tabeta K, Sugita N, Yoshie, Y. Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Arch Oral Biol. 2013;58:724-30.


17. Morozumi T, Kubota T, Abe D, Shimizu T, Komatsu Y, Yoshie H. Effects of irrigation with an antiseptic and oral administration of azithromycin on bacteremia caused by scaling and root planning. J Periodontol. 2010;81:1555-63.


18. Sakamoto M, Takeuchi Y, Umeda M, Ishikawa I, Benno Y. Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis. J Med Microbiol. 2003;52:79-89.


19. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409-19.
PMid:23134607 PMCid:PMC3653317


20. Valderrama P, Blansett JA, Gonzalez MG, Cantu MG, Wilson TG. Detoxification of Implant surfaces affected by peri-implant disease: an overview of non-surgical methods. Open Dent J. 2014;8:77-84.
PMid:24894571 PMCid:PMC4040927


21. Ando Y, Aoki A, Watanabe H, Ishikawa I. Bactericidal effect of erbium YAG laser on periodontopathic bacteria. Lasers Surg Med. 1996;19:190-200.<190::AID-LSM11>3.0.CO;2-B


22. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J periodontol. 1993; 64: 474-84.


23. Söder B, Airila Mĺnsson S, Söder PÖ, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodont Res. 2006;41:411-7.


24. Kubota T, Itagaki M, Hoshino C, Nagata M, Morozumi T, Kobayashi T, et al. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. J periodontal. 2008;79:166-73.


25. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem. 1991;266:11436-41.


26. Westerlund U, Ingman T, Lukinmaa PL, Salo T, Kjeldsen L, Borregaard N, et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res. 1996;75:1553-63.


27. Ma J, Kitti U, Hanemaaier R, Teronen OP, Sorsa TA, Natah S, et al. Gelatinase B is associated with peri-implant bone loss. Clin Oral Implants Res. 2003;14:709-13.


28. Özçakır-Tomruk C, Chiquet M, Mericske-Stern R. Tenascin-C and matrix metalloproteinase- 9 levels in crevicular fluid of teeth and implants. Clin Implant Dent and Relat Res. 2012;14:672-81.